首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Respiratory medicine case reports

缩写:

ISSN:2213-0071

e-ISSN:

IF/分区:0.7/Q4

文章目录 更多期刊信息

共收录本刊相关文章索引2461
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Mark G Evans,Anthony Crymes,Adam Bedeir et al. Mark G Evans et al.
Adult granulosa cell tumor (GCT) is an uncommon sex cord-stromal neoplasm of the ovary. It typically demonstrates locoregional spread, and disease outside of the pelvis as metastasis is uncommon. Only a rare case of primary thoracic adult G...
Masayuki Mori,Masayuki Shirasawa,Akihito Oguri et al. Masayuki Mori et al.
Lung cancer often causes bone metastasis, and denosumab is administered to bone metastases to prevent bone-related adverse events. One of the important side effects of denosumab is hypocalcemia, but this is generally not a problem, as it is...
Yuki Yamaguchi,Satoshi Horino,Hiroki Miyabayashi et al. Yuki Yamaguchi et al.
Propranolol, a nonselective adrenergic beta-receptor blocker, is the first-line drug used for the treatment of infantile hemangiomas (IH). However, its use is contraindicated in patients with bronchial asthma. Nevertheless, studies assessin...
Bilal Alqam,Sarah Medrek Bilal Alqam
An 81-year-old man with a history of interstitial lung disease attributed to idiopathic pulmonary fibrosis, severe aortic stenosis, and stable coronary artery disease was started on inhaled treprostinil for pulmonary hypertension associated...
Yuki Hatakeyama,Jun Sakakibara-Konishi,Masato Tarumi et al. Yuki Hatakeyama et al.
Based on the results of a multicenter phase II study of patients with previously treated thymic carcinoma, lenvatinib administration for unresectable thymic cancer has been covered under insurance in Japan since 2021. However, patients with...
Hiroki Iida,Kenichiro Atsumi,Naohiro Kadoma et al. Hiroki Iida et al.
Pembrolizumab is an immune checkpoint inhibitor (ICI) of programmed cell death-1 category, used for treating various types of cancer. ICIs can sometimes result in immune-related adverse events. Allergic bronchopulmonary mycosis (ABPM) induc...
Mark A Colantonio,Sanjana Aggarwal,Himanshu Deshwal Mark A Colantonio
Alpha-1 antitrypsin is a relatively well-known genetic disease known to primarily affect the lungs and liver. Extrapulmonary manifestations of this disease have been reported, including vascular aneurysms. To date, few cases have reported v...
N Garancini,M Ghezzi,A Farolfi et al. N Garancini et al.
Mutations of KCNT1 gene, encoding for a sodium-gated potassium channel, are causative of a wide spectrum of epilepsies and neurodevelopmental disorders; cardiovascular involvement also seems to be significant, with cardiac arrhythmia and, l...
Stefanie Klampfleitner,Andreas Fertl,Ositha Prinz et al. Stefanie Klampfleitner et al.
Introduction: Nintedanib is a tyrosine kinase inhibitor and has been approved for the treatment of idiopathic pulmonary fibrosis (IPF) since 2020. In Clinical trials, the antifibrotic effect of nintedanib was shown. ...
Julia Schearer,Christopher Merrick Julia Schearer
Pneumocystis pneumonia (PCP) is a fungal infection with primary occurrence in immunocompromised individuals by the etiologic agent Pneumocystis jirovecii. In those without previously identified risk factors, maintaining an index of suspicio...